5-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine → HCID 22240294, compound
Reaction equation
CC1(C)C(C)(C)OB([C:9]2[C:10]3[C:15]([C:16]4[CH:17]=[CH:18][CH:19]=[CH:20][C:21]=4[CH:22]=2)=[CH:14][CH:13]=[CH:12][CH:11]=3)O1.Cl[C:25]1[CH:26]=[C:27]([CH2:31][N:32]2[CH:36]=[CH:35][N:34]=[C:33]2[CH3:37])[N:28]=[N:29][CH:30]=1>>[CH3:37][C:33]1[N:32]([CH2:31][C:27]2[N:28]=[N:29][CH:30]=[C:25]([C:9]3[C:10]4[C:15]([C:16]5[CH:17]=[CH:18][CH:19]=[CH:20][C:21]=5[CH:22]=3)=[CH:14][CH:13]=[CH:12][CH:11]=4)[CH:26]=2)[CH:36]=[CH:35][N:34]=1Participants
3
Procedure
The title compound, MS: m/e=351.4 (M+H+), was prepared from 4,4,5,5-tetramethyl-2-phenanthren-9-yl-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine.
Sources & evidence
- ORD record
- ord-8498d2d6b4064ede939d1e8c7442ab03
- Source dataset
- uspto-grants-2006_02
- Patent number
- US07005432B2
Reaction notes
Loading…